\-\ Texto\\:\\ \ \(0\)\
\-\ examination\\:\\ scalp\\:\\ erythema\\ with\\ scale\\.\\ face\\:\\ violaceous\\ macules\\ resembling\\ early\\ heliotrope\\;\\ central\\ facial\\ erythema\\.\ \(0\)\
\-\ trunk\\ \\&\\ extremities\\:\\ violaceous\\,\\ indurated\\ plaques\\.\\ hands\\:\\ firm\\ erythematous\\ papules\\ over\\ joints\\.\\ fingernails\\:\\ ragged\\ cuticles\\ and\\ tortuous\\ dilated\\ capillary\\ loops\\.\\ neuro\\:\\ strength\\ 4\\/5\\ in\\ upper\\ extremity\\/shoulder\\ girdle\\ musculature\\.\ \(0\)\
\-\ course\\:\\ the\\ patient\\'s\\ symptoms\\ improved\\ within\\ 3\\ days\\ of\\ stopping\\ zocor\\.\\ creatinine\\ kinase\\ levels\\ \\(serial\\)\\ also\\ declined\\ concurrently\\ with\\ the\\ resolution\\ of\\ the\\ patient\\'s\\ skin\\ findings\\ after\\ stopping\\ zocor\\.\ \(0\)\
\-\ laboratory\\:\\ ana\\ negative\\;\\ anti\\-rnp\\,\\ anti\\-smith\\,\\ anti\\-ro\\/la\\,\\ anti\\-jo\\ antibodies\\ negative\\;\\ hepatitis\\ panel\\ negative\\;\\ tsh\\,\\ 5\\.90\\ \\(slightly\\ elevated\\)\\;\\ esr\\ 40\\ \\(elevated\\)\\,\\ rheumatoid\\ factor\\,\\ negative\\;\\ creatinine\\ kinase\\ 2487\\ \\(high\\)\\;\\ lfts\\,\\ cbc\\,\\ chem\\ 10\\:\\ normal\\;\\ age\\ appropriate\\ cancer\\ screening\\:\\ negative\\ \\(psa\\,\\ cxr\\,\\ recent\\ colonoscopy\\)\\;ct\\ scan\\ \\(neck\\)\\:\\ 16mm\\ supraclavicular\\ ln\\ on\\ left\\ \\(fna\\:\\ reactive\\)\\;\\ fullness\\ at\\ base\\ of\\ tongue\\ \\(benign\\ per\\ laryngoscopy\\ done\\ by\\ ent\\)\ \(0\)\
\-\ histopathology\\:\\ the\\ biopsy\\ shows\\ a\\ vacuolar\\ interface\\ dermatitis\\ with\\ increased\\ interstitial\\ mucin\\.\ \(0\)\
\-\ case\\ 13\\ \\(27th\\ annual\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ 2003\\)\\ dermatomyositis\\-like\\ eruption\\ due\\ to\\ zocor\ \(0\)\
\-\ history\\:\\ 66\\ y\\/o\\ hispanic\\ male\\ with\\ a\\ 5\\ week\\ history\\ of\\ pruritic\\ erythematous\\ changes\\ to\\ the\\ skin\\ of\\ his\\ upper\\ back\\,\\ chest\\,\\ arms\\,\\ hands\\,\\ and\\ scalp\\.\\ the\\ eruption\\ was\\ accompanied\\ by\\ progressively\\ severe\\ myalgias\\ localized\\ to\\ the\\ girdle\\ muscies\\ of\\ the\\ shoulder\\ and\\ upper\\ extremities\\.\\ the\\ only\\ recent\\ medication\\ change\\ was\\ zocor\\ \\(simvastatin\\)\\ from\\ 20\\ mg\\ qd\\ to\\ 40\\ mg\\ qd\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ zocor\\:\\ 0\\.35900381768668865\ \(0\)\
\-\ negative\\:\\ 0\\.18800831765016862\ \(0\)\
\-\ girdle\\:\\ 0\\.17475010868516253\ \(0\)\
\-\ stopping\\:\\ 0\\.1599896692154592\ \(0\)\
\-\ kinase\\:\\ 0\\.1599896692154592\ \(0\)\
\-\ violaceous\\:\\ 0\\.1579600567762774\ \(0\)\
\-\ eruption\\:\\ 0\\.1579600567762774\ \(0\)\
\-\ qd\\:\\ 0\\.14047742958757406\ \(0\)\
\-\ creatinine\\:\\ 0\\.12368737767868891\ \(0\)\
\-\ scalp\\:\\ 0\\.12330367697663606\ \(0\)\
\-\ erythematous\\:\\ 0\\.12330367697663606\ \(0\)\
\-\ hands\\:\\ 0\\.11518252624309475\ \(0\)\
\-\ erythema\\:\\ 0\\.10991757323451333\ \(0\)\
\-\ the\\:\\ 0\\.10907251637639202\ \(0\)\
\-\ mg\\:\\ 0\\.10603506980875425\ \(0\)\
\-\ upper\\:\\ 0\\.09737022391879219\ \(0\)\
\-\ muscies\\:\\ 0\\.09713117415652382\ \(0\)\
\-\ simvastatin\\:\\ 0\\.09713117415652382\ \(0\)\
\-\ shoulder\\:\\ 0\\.09436097326738299\ \(0\)\
\-\ heliotrope\\:\\ 0\\.09281402236455338\ \(0\)\
\-\ cuticles\\:\\ 0\\.09281402236455338\ \(0\)\
\-\ 2487\\:\\ 0\\.09281402236455338\ \(0\)\
\-\ 16mm\\:\\ 0\\.09281402236455338\ \(0\)\
\-\ extremities\\:\\ 0\\.09231360775270502\ \(0\)\
\-\ skin\\:\\ 0\\.09036481063945336\ \(0\)\
\-\ fingernails\\:\\ 0\\.08975095442167216\ \(0\)\
\-\ ln\\:\\ 0\\.08975095442167216\ \(0\)\
\-\ 40\\:\\ 0\\.08933740334986781\ \(0\)\
\-\ vacuolar\\:\\ 0\\.08737505434258126\ \(0\)\
\-\ ragged\\:\\ 0\\.08543380262970171\ \(0\)\
\-\ concurrently\\:\\ 0\\.08379249769287302\ \(0\)\
\-\ laryngoscopy\\:\\ 0\\.08379249769287302\ \(0\)\
\-\ elevated\\:\\ 0\\.08281000743634137\ \(0\)\
\-\ resembling\\:\\ 0\\.08237073468682052\ \(0\)\
\-\ recent\\:\\ 0\\.08224958528168395\ \(0\)\
\-\ myalgias\\:\\ 0\\.08111665083773126\ \(0\)\
\-\ macules\\:\\ 0\\.0799948346077296\ \(0\)\
\-\ pruritic\\:\\ 0\\.07805358289485005\ \(0\)\
\-\ indurated\\:\\ 0\\.07720133565592169\ \(0\)\
\-\ antibodies\\:\\ 0\\.07499051495196885\ \(0\)\
\-\ mucin\\:\\ 0\\.07499051495196885\ \(0\)\
\-\ psa\\:\\ 0\\.0737364311028796\ \(0\)\
\-\ dermatitis\\:\\ 0\\.0731607554244398\ \(0\)\
\-\ declined\\:\\ 0\\.07261461487287794\ \(0\)\
\-\ 27th\\:\\ 0\\.07159980865328702\ \(0\)\
\-\ of\\:\\ 0\\.07131539696637884\ \(0\)\
\-\ fna\\:\\ 0\\.07112651267145935\ \(0\)\
\-\ ana\\:\\ 0\\.07067336315999839\ \(0\)\
\-\ lfts\\:\\ 0\\.07023871479378703\ \(0\)\
\-\ papules\\:\\ 0\\.06941927931090915\ \(0\)\
\-\ chem\\:\\ 0\\.06941927931090915\ \(0\)\
\-\ hispanic\\:\\ 0\\.067948336511129\ \(0\)\
\-\ trunk\\:\\ 0\\.06761029521711719\ \(0\)\
\-\ tortuous\\:\\ 0\\.06728265686131657\ \(0\)\
\-\ supraclavicular\\:\\ 0\\.06635621136802794\ \(0\)\
\-\ interface\\:\\ 0\\.06635621136802794\ \(0\)\
\-\ accompanied\\:\\ 0\\.06635621136802794\ \(0\)\
\-\ musculature\\:\\ 0\\.06606448335457131\ \(0\)\
\-\ tongue\\:\\ 0\\.06550396412909956\ \(0\)\
\-\ ent\\:\\ 0\\.06471490643119923\ \(0\)\
\-\ capillary\\:\\ 0\\.06374629293660769\ \(0\)\
\-\ panel\\:\\ 0\\.06374629293660769\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.06329314342514673\ \(0\)\
\-\ hepatitis\\:\\ 0\\.06244089618621836\ \(0\)\
\-\ fullness\\:\\ 0\\.061843688839344456\ \(0\)\
\-\ plaques\\:\\ 0\\.06127820694474901\ \(0\)\
\-\ histopathology\\:\\ 0\\.06127820694474901\ \(0\)\
\-\ arms\\:\\ 0\\.06127820694474901\ \(0\)\
\-\ seminar\\:\\ 0\\.06109619556538728\ \(0\)\
\-\ to\\:\\ 0\\.060736203043971704\ \(0\)\
\-\ scale\\:\\ 0\\.06056811677627733\ \(0\)\
\-\ uniformed\\:\\ 0\\.06056811677627733\ \(0\)\
\-\ services\\:\\ 0\\.05958458049520358\ \(0\)\
\-\ dermatology\\:\\ 0\\.05942914114463723\ \(0\)\
\-\ progressively\\:\\ 0\\.05942914114463723\ \(0\)\
\-\ tsh\\:\\ 0\\.05868426361971965\ \(0\)\
\-\ factor\\:\\ 0\\.056961055152778564\ \(0\)\
\-\ 66\\:\\ 0\\.056961055152778564\ \(0\)\
\-\ neuro\\:\\ 0\\.05660009155408537\ \(0\)\
\-\ annual\\:\\ 0\\.056137087894385505\ \(0\)\
\-\ medication\\:\\ 0\\.056137087894385505\ \(0\)\
\-\ serial\\:\\ 0\\.055912923690295074\ \(0\)\
\-\ esr\\:\\ 0\\.05558528533449445\ \(0\)\
\-\ loops\\:\\ 0\\.05516355074356187\ \(0\)\
\-\ firm\\:\\ 0\\.055060676451366704\ \(0\)\
\-\ interstitial\\:\\ 0\\.055060676451366704\ \(0\)\
\-\ face\\:\\ 0\\.05475788619648679\ \(0\)\
\-\ 2003\\:\\ 0\\.05465883984120582\ \(0\)\
\-\ localized\\:\\ 0\\.054560706368543155\ \(0\)\
\-\ improved\\:\\ 0\\.05389798720989735\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.05353702361120416\ \(0\)\
\-\ appropriate\\:\\ 0\\.053361029415620626\ \(0\)\
\-\ joints\\:\\ 0\\.05220436076035191\ \(0\)\
\-\ reactive\\:\\ 0\\.052126357434099976\ \(0\)\
\-\ by\\:\\ 0\\.051584634019077986\ \(0\)\
\-\ strength\\:\\ 0\\.05088091245478455\ \(0\)\
\-\ cbc\\:\\ 0\\.0506754898821471\ \(0\)\
\-\ per\\:\\ 0\\.050407616472956863\ \(0\)\
\-\ facial\\:\\ 0\\.05008198233483975\ \(0\)\
\-\ screening\\:\\ 0\\.04933883849166697\ \(0\)\
\-\ resolution\\:\\ 0\\.0492791890000156\ \(0\)\
\-\ cxr\\:\\ 0\\.048588304115272166\ \(0\)\
\-\ done\\:\\ 0\\.04831316202466722\ \(0\)\
\-\ levels\\:\\ 0\\.048151426159185176\ \(0\)\
\-\ with\\:\\ 0\\.04757200526604849\ \(0\)\
\-\ slightly\\:\\ 0\\.04737766646163514\ \(0\)\
\-\ history\\:\\ 0\\.04640985590302771\ \(0\)\
\-\ base\\:\\ 0\\.04620126075268152\ \(0\)\
\-\ change\\:\\ 0\\.046024536257264916\ \(0\)\
\-\ 13\\:\\ 0\\.04580767730657401\ \(0\)\
\-\ course\\:\\ 0\\.04486335803636321\ \(0\)\
\-\ laboratory\\:\\ 0\\.044105215358343025\ \(0\)\
\-\ early\\:\\ 0\\.043780903797261586\ \(0\)\
\-\ dilated\\:\\ 0\\.04350069271993289\ \(0\)\
\-\ biopsy\\:\\ 0\\.042574247226644255\ \(0\)\
\-\ was\\:\\ 0\\.04233466878692485\ \(0\)\
\-\ benign\\:\\ 0\\.04172199998771589\ \(0\)\
\-\ week\\:\\ 0\\.04085176726070664\ \(0\)\
\-\ central\\:\\ 0\\.04055931074624654\ \(0\)\
\-\ back\\:\\ 0\\.0405069892335298\ \(0\)\
\-\ cancer\\:\\ 0\\.04045492357275314\ \(0\)\
\-\ patient\\:\\ 0\\.039509186079311635\ \(0\)\
\-\ 20\\:\\ 0\\.03918354092796243\ \(0\)\
\-\ examination\\:\\ 0\\.0388656842967011\ \(0\)\
\-\ days\\:\\ 0\\.03844894578570022\ \(0\)\
\-\ severe\\:\\ 0\\.03844894578570022\ \(0\)\
\-\ age\\:\\ 0\\.038131089154438885\ \(0\)\
\-\ only\\:\\ 0\\.037944832397663594\ \(0\)\
\-\ and\\:\\ 0\\.03765147414054711\ \(0\)\
\-\ neck\\:\\ 0\\.03715430942673926\ \(0\)\
\-\ his\\:\\ 0\\.0368353324286213\ \(0\)\
\-\ changes\\:\\ 0\\.03670671680971087\ \(0\)\
\-\ scan\\:\\ 0\\.03603439809099299\ \(0\)\
\-\ shows\\:\\ 0\\.035647177003253545\ \(0\)\
\-\ 10\\:\\ 0\\.03551572587175596\ \(0\)\
\-\ due\\:\\ 0\\.03491258186099134\ \(0\)\
\-\ high\\:\\ 0\\.03451874953031228\ \(0\)\
\-\ over\\:\\ 0\\.03377226448574009\ \(0\)\
\-\ symptoms\\:\\ 0\\.03323167090299978\ \(0\)\
\-\ increased\\:\\ 0\\.032843508608063066\ \(0\)\
\-\ chest\\:\\ 0\\.032059897618310566\ \(0\)\
\-\ case\\:\\ 0\\.030513447708938306\ \(0\)\
\-\ findings\\:\\ 0\\.02997598787190694\ \(0\)\
\-\ after\\:\\ 0\\.029464359247900168\ \(0\)\
\-\ also\\:\\ 0\\.02856879372524785\ \(0\)\
\-\ within\\:\\ 0\\.027973442027679273\ \(0\)\
\-\ male\\:\\ 0\\.02704230648964407\ \(0\)\
\-\ normal\\:\\ 0\\.02479837929582633\ \(0\)\
\-\ from\\:\\ 0\\.02412203443322915\ \(0\)\
\-\ ct\\:\\ 0\\.023123024421401458\ \(0\)\
\-\ at\\:\\ 0\\.022941013042039726\ \(0\)\
\-\ left\\:\\ 0\\.02071860630540923\ \(0\)\
\-\ on\\:\\ 0\\.018343519968258577\ \(0\)\
\-\ in\\:\\ 0\\.015109314894594567\ \(0\)\
